BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1182703)

  • 1. Selective destruction of cultured tumor cells with uncontrolled nuclear division by cytochalasin B and cytosine arabinoside.
    O'Neill FJ
    Cancer Res; 1975 Nov; 35(11 Pt 1):3111-5. PubMed ID: 1182703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of controlled nuclear division in BHK21 cells passed in vivo.
    O'Neill FJ
    Cancer Res; 1976 Jun; 36(6):2019-24. PubMed ID: 944618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD; Murphey MM
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of cultured mammalian cells to cytochalasin B in multinucleation.
    Takii M; Takaki R; Yamagami H
    Jpn J Exp Med; 1976 Apr; 46(2):95-100. PubMed ID: 933370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma.
    Bousquet PF; Paulsen LA; Fondy C; Lipski KM; Loucy KJ; Fondy TP
    Cancer Res; 1990 Mar; 50(5):1431-9. PubMed ID: 2302708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
    Crouch GD; Kalebic T; Tsokos M; Helman LJ
    Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
    Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM
    Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent effects on in vitro development following cytochalasin B treatment of 8-cell mouse embryos.
    Granholm NH; Brenner GM; Rector JT
    J Embryol Exp Morphol; 1979 Jun; 51():97-108. PubMed ID: 479751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytosine arabinoside on the growth and phenotypic expression of GI-ME-N, a new human neuroblastoma cell line.
    Ponzoni M; Melodia A; Cirillo C; Casalaro A; Cornaglia-Ferraris P
    Prog Clin Biol Res; 1988; 271():437-48. PubMed ID: 3406012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between preneopastic and neoplastic mammary cell populations in vitro by cytochalasin B-induced multinucleation.
    Medina D; Oborn CJ; Asch BB
    Cancer Res; 1980 Feb; 40(2):329-33. PubMed ID: 7356516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro growth control phenotypes of transformed rodent cells prior to and following tumorigenesis.
    O'Neill FJ; Renzetti L
    Cancer Res; 1983 Feb; 43(2):521-8. PubMed ID: 6848175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T; Muus P; Haanen C; Van der Lely N; Koekman E; Van der Locht A; Blankenborg G; Wessels J
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of multipolar mitoses in the proliferation of multinucleate cells induced by cytochalasin B].
    Petrashchuk OM; Onishchenko GE
    Tsitologiia; 1987 Jul; 29(7):794-801. PubMed ID: 3672640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of cell killing by 1-beta-D-arabinofuranosylcytosine and its relevance to molecular mechanisms of cytotoxicity.
    Crowther PJ; Cooper IA; Woodcock DM
    Cancer Res; 1985 Sep; 45(9):4291-300. PubMed ID: 4028015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors.
    Waga K; Furusawa S; Nagashima S; Saito K; Shishido H
    Int J Hematol; 1992 Aug; 56(1):17-27. PubMed ID: 1391803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosine arabinoside induces programmed endothelial cell death through the caspase-3 pathway.
    Moore IM; Merkle CJ; Miketova P; Salyer RK; Torres BJ; Schaeffer RC; Montgomery DW
    Biol Res Nurs; 2006 Apr; 7(4):289-96. PubMed ID: 16581899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.